This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Grotz WH, Breitenfeldt MK, Braune SW, Allmann KH, Krause TM, Rump JA et al. Calcineurin-inhibitor induced pain syndrome (CIPS): a severe disabling complication after organ transplantation. Transpl Int 2001; 14: 16–23.
Kida A, Ohashi K, Kobayashii T, Sakai M, Yamashita T, Akiyama H et al. Incapacitating lower limb pain syndrome in cord blood stem cell transplant recipients with calcineurin inhibitor. Pathol Oncol Res 2004; 10: 204–206.
Kida A, Ohashi K, Tanaka C, Kamata N, Akiyama H, Sakamaki H . Calcineurin-inhibitor pain syndrome following haematopoietic stem cell transplantation. Br J Haematol 2004; 126: 288.
Lavoratore SR, Navarro OM, Grunebaum E, Ali M, Koo A, Schechter T et al. Cyclosporine-induced pain syndrome in a child undergoing hematopoietic stem cell transplant. Ann Pharmacother 2009; 43: 767–771.
Noda Y, Kodama K, Yasuda T, Takahashi S . Calcineurin-inhibitor-induced pain syndrome after bone marrow transplantation. J Anesth 2008; 22: 61–63.
Gauthier VJ, Barbosa LM . Bone pain in transplant recipients responsive to calcium channel blockers. Ann Intern Med 1994; 121: 863–865.
Smith HS . Calcineurin as a nociceptor modulator. Pain Physician 2009; 12: E309–E318.
Mori Y, Miyamoto T, Nagafuji K, Kamezaki K, Yamamoto A, Saito N et al. High incidence of human herpes virus 6-associated encephalitis/myelitis following a second unrelated cord blood transplantation. Biol Blood Marrow Transplant 2010; 16: 1596–1602.
Acknowledgements
We are grateful to the patients who participated in this study. We thank the staff of the Hematology Division at Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, for their excellent patient care. This study was supported in part by a grant for clinical cancer research from the Ministry of Health, Labor and Welfare of Japan.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Kakihana, K., Ohashi, K., Murata, Y. et al. Clinical features of calcineurin inhibitor-induced pain syndrome after allo-SCT. Bone Marrow Transplant 47, 593–595 (2012). https://doi.org/10.1038/bmt.2011.120
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2011.120
This article is cited by
-
Presynaptic NMDA receptors control nociceptive transmission at the spinal cord level in neuropathic pain
Cellular and Molecular Life Sciences (2019)
-
Successful treatment of calcineurin inhibitor-induced pain syndrome with acute graft versus host disease by switching calcineurin inhibitors followed by pregabalin
Annals of Hematology (2017)